References

AHIP (America’s Health Insurance Plans). 2010. Health Literacy. http://www.ahip.org/content/default.aspx?bc=39|41|22050 (accessed June 28, 2010).

Budnitz, D. S., D. A. Pollock, K. N. Weidenbach, A. B. Mendelsohn, T. J. Schroeder, and J. L. Annest. 2006. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events. JAMA 296(15):1858-1866.

Budnitz, D. S., L. L. Lewis, N. Shehab, and D. Birnkrant. 2009. CDC and FDA Response to Risk of Confusion in Dosing Tamiflu Oral Suspension. New England Journal of Medicine 361(19):1913-1914.

Chen, L., S. Schneider, and P. Wax. 2002. Knowledge about acetominophen toxicity among emergency department visitors. Vet Human Toxicology 44:370-373.

Chowdhury, B. A., and G. D. Pan. 2010. The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma. New England Journal of Medicine 362(13):1169-1171.

CMS (Centers for Medicare & Medicaid Services). 2009. CMS and ONC Issue Regulations Proposing a Definition of “Meaningful Use” and Setting Standards for Electronic Health Record Incentive Program. http://www.hhs.gov/news/press/2009pres/12/20091230a.html (accessed June 29, 2010).

Cohen, A. L., D.S. Budnitz, K. N. Weidenbach, D. B. Jernigan, T. J. Schroeder, N. Shehab, and D. A. Pollock. 2008. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events in Children and Adolescents. The Journal of Pediatrics 152(3):416-421.e2.

Davis, T. C., R. Parker, and M. S. Wolf. 2006. To err is really human: misunderstanding medication labels. Paper read at ACP Foundation.

Delp, C., and J. Jones. 1996. Communicating Information to Patients: The Use of Cartoon Illustrations to Improve Comprehension of Instructions. Academic Emergency Medicine 3(3):264-270.

FDA (Food and Drug Administration). 2006. Guidance: Useful Written Consumer Medical Information (CMI). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm080602.pdf (accessed June 25, 2010).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 57
References AHIP (America’s Health Insurance Plans). 2010. Health Literacy. http://www.ahip.org/ content/default.aspx?bc=39|41|22050 (accessed June 28, 2010). Budnitz, D. S., D. A. Pollock, K. N. Weidenbach, A. B. Mendelsohn, T. J. Schroeder, and J. L. Annest. 2006. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events. JAMA 296(15):1858-1866. Budnitz, D. S., L. L. Lewis, N. Shehab, and D. Birnkrant. 2009. CDC and FDA Response to Risk of Confusion in Dosing Tamiflu Oral Suspension. new england Journal of Medicine 361(19):1913-1914. Chen, L., S. Schneider, and P. Wax. 2002. Knowledge about acetominophen toxicity among emergency department visitors. Vet Human Toxicology 44:370-373. Chowdhury, B. A., and G. D. Pan. 2010. The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma. new england Journal of Medicine 362(13):1169-1171. CMS (Centers for Medicare & Medicaid Services). 2009. CMS and onC Issue Regulations Proposing a Definition of “Meaningful Use” and Setting Standards for electronic Health Record Incentive Program. http://www.hhs.gov/news/press/2009pres/12/20091230a. html (accessed June 29, 2010). Cohen, A. L., D.S. Budnitz, K. N. Weidenbach, D. B. Jernigan, T. J. Schroeder, N. Shehab, and D. A. Pollock. 2008. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events in Children and Adolescents. The Journal of Pediatrics 152(3):416-421.e2. Davis, T. C., R. Parker, and M. S. Wolf. 2006. To err is really human: misunderstanding medication labels. Paper read at ACP Foundation. Delp, C., and J. Jones. 1996. Communicating Information to Patients: The Use of Cartoon Illustrations to Improve Comprehension of Instructions. Academic emergency Medicine 3(3):264-270. FDA (Food and Drug Administration). 2006. Guidance: Useful Written Consumer Medical Information (CMI). http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ucm080602.pdf (accessed June 25, 2010). 

OCR for page 57
 THe SAFe USe InITIATIVe AnD HeALTH LITeRACY ———. 2009a. FDA’s Safe Use Initiative. http://www.fda.gov/downloads/Drugs/Drug Safety/UCM188961.pdf (accessed June 28, 2010). ———. 2009b. FDA Unveils Safe Use Initiative That Targets Preventable Harm from Medication Use. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ ucm189081.htm (accessed June 28, 2010). ———. 2009c. Guidance for Industry. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM188992.pdf (accessed June 29, 2010). Fosnocht, D., J. R. Taylor, and E. M. Caravati. 2008. Emergency department patient knowl - edge concerning acetaminophen (paracetamol) in over-the-counter and prescription analgesics. emergency Medicine Journal 25:213-216. GAO (Government Accountability Office). 2000. Adverse Drug events: The Magnitude of Health Risk if Uncertain Because of Limited Incidence Data. http://www.gao.gov/new. items/he00021.pdf (accessed June 29, 2010). Griffiths, J. 2010. Identify Activites Around Which to Build Partnerships for Patient Centered Drug Safety: Insurer. Presentation at Institute of Medicine Workshop on the Safe Use Initiative and Health Literacy, in Washington, DC. IOM (Institute of Medicine). 2004. Health literacy: A prescription to end confusion. Washington, DC: The National Academies Press. ———. 2007. Preventing Medication errors. Washington, DC: The National Academies Press. ———. 2008. Standardizing medication labels: Confusing patients less. Washington, DC: The National Academies Press. ———. 2009. Measures of Health Literacy. Washington, DC: The National Academies Press. Larson, A. M., J. Polson, R. J. Fontana, T. J. Davern, E. Lalani, L. S. Hynan, J. S. Reisch, F. V. Schiødt, G. Ostapowicz, A. O. Shakil, and W. M. Lee. 2005. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 42(6):1364-1372. Lokker, N., L. Sanders, E. M. Perrin, D. Kumar, J. Finkle, V. Franco, L. Choi, P. E. Johnston, and R. L. Rothman. 2009. Parental Misinterpretations of Over-the-Counter Pediatric Cough and Cold Medication Labels. Pediatrics 123(6):1464-1471. NCPA (National Community Pharmacists Association). 2006. national Community Pharma- cists Association and Pharmacists for the Protection of Patient Care Adherence Survey 00 . http://www.ncpanet.org/media/releases/2006/take_as_directed.php (accessed June 29, 2010). NCPIE (National Coalition for Patient Involvement in Education). 2007. Enhancing Pre - scription Medicine Adherence: A National Action Plan. http://www.talkaboutrx. org/documents/enhancing_prescription_medicine_adherence.pdf (accessed June 29, 2010). Parker, R. M., S. C. Ratzan, and N. Lurie. 2003. Health Literacy: A Policy Challenge For Advancing High-Quality Health Care. Health Affairs 22(4):147-153. Parker, R. M., M. S. Wolf, K. L. Jacobson, and A. J. J. Wood. 2009. Risk of Confusion in Dosing Tamiflu Oral Suspension in Children. new england Journal of Medicine 361(19):1912- 1913. Schillie, S. F., N. Shehab, K. E. Thomas, and D. S. Budnitz. 2009. Medication Overdoses Lead- ing to Emergency Department Visits Among Children. American Journal of Preventive Medicine 37(3):181-187. Schillinger, D., E. L. Machtinger, F. Wang, J. Palacios, M. Rodriguez, and A. Bindman. 2006. Language, Literacy, and Communication Regarding Medication in an Anticoagulation Clinic: A Comparison of Verbal vs. Visual Assessment. Journal of Health Communication: International Perspectives 11(7):651-664.

OCR for page 57
 ReFeRenCeS Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. 1996. Action Plan for the Provision on Useful Prescription Medicine Information. Stumpf, J. L., A. J. Skyles, C. Alaniz, and S. R. Erickson. 2007. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. Journal of the American Pharmacists Association 47(1):U35-U53. USP (United States Pharamacopeia). 2010. Recommendations to the Safe Medication Use ex- pert Committee by the Health Literacy and Prescription Container Labeling Advisory Panel . http://www.usp.org/pdf/EN/USPNF/recommendContainerLabeling.pdf (accessed June 29, 2010). Wolf, M. S. 2010. Health Literacy Tasks for Over-the-Counter Drug Safety. Presentation at Institute of Medicine Workshop on the Safe Use Initiative and Health Literacy, in Washington, DC. Wolf, M. S., T. C. Davis, H. H. Tilson, P. F. B. Iii, and R. M. Parker. 2006. Misunderstanding of prescription drug warning labels among patients with low literacy. American Journal of Health-System Pharmacy 63(11):1048-1055. Woodcock, J. 2009. A Difficult Balance—Pain Management, Drug Safety, and the FDA. new england Journal of Medicine 361(22):2105-2107. Yin, H. S. 2010. Current Status of Over-the-Counter Labels. Presentation at Institute of Medi- cine Workshop on the Safe Use Initiative and Health Literacy, in Washington, DC.

OCR for page 57